Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients Wi

Clinical Trial Details

USOR 16065

Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma (UNITY-NHL)

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Non-Hodgkins Lymphoma
Study Type: Interventional
Phase: III
Study Start Date: 02/10/2017
Study Completion Date: 07/2022

This is a randomized study to assess the efficacy and safety of the study drug ublituximab and TGR-1202 with or without Bendamustine and then TGR-1202 alone in patients with previously treated Non-Hodgkin’s Lymphoma.

NCT Number
NCT02793583
Principal Investigator(s)
Mohit Narang, MD
Sponsor(s)
TG Therapeutics, Inc.
Participant Eligibility
  • Age: 18 - No Maximum
  • Gender: Male, Female

Location

  • Shady Grove Adventist Aquilino Cancer Center
    9905 Medical Center Drive
    Rockville, MD 20850
    Main: 240-826-6297

Find a Doctor

Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.

View Doctors

Set Your Location

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.